Suchergebnisse - "Garcia-Manero, Guillermo"

PubPharm (1.396)

1

Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL

enthalten in: bioRxiv.org | 2024

von Zhao, Y. | Short, N. | Kantarjian, H. | +19

2

Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction : a single-centre, single-arm, phase 2 trial

enthalten in: The Lancet. Haematology | 2024

von Bazinet, A. | Kantarjian, H. | Bataller, A. | +17

3

Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome

enthalten in: Blood advances | 2024

von DiNardo, C. | Roboz, G. | Watts, J. | +15

4

Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms : Frequency and clinical implications

enthalten in: American journal of hematology | 2024

von Abuasab, T. | Borthakur, G. | Kanagal-Shamanna, R. | +15

5

Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia : a phase 2 study

enthalten in: The Lancet. Haematology | 2024

von Bazinet, A. | Garcia-Manero, G. | Short, N. | +22

6

Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia

enthalten in: Cancer | 2024

von Jabbour, E. | Haddad, F. | Sasaki, K. | +16

7

Sotatercept for anemia of myelofibrosis : a phase II investigator-initiated study

enthalten in: Haematologica | 2024

von Bose, P. | Masarova, L. | Pemmaraju, N. | +21

8

Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Short, N. | Daver, N. | Dinardo, C. | +21

9

Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Bazinet, A. | Desikan, S. | Li, Z. | +17

10

Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL

enthalten in: Blood | 2024

von Zhao, Y. | Short, N. | Kantarjian, H. | +19

UpdateOf: medRxiv. 2023 Dec 09;:. - PMID 38106221

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[140]